Skip to Content
Merck
  • Formation of drug/surfactant catanionic vesicles and their application in sustained drug release.

Formation of drug/surfactant catanionic vesicles and their application in sustained drug release.

International journal of pharmaceutics (2012-08-09)
Yue Jiang, Feifei Li, Yuxia Luan, Wenting Cao, Xiaoqing Ji, Lanxia Zhao, Longlong Zhang, Zhonghao Li
ABSTRACT

The aggregation behavior of the cationic drug/anionic surfactant vesicles formed by tetracaine hydrochloride (TH) and double-chain surfactant, sodium bis(2-ethylhexyl)sulfosuccinate (AOT), was investigated. By controlling the molar ratio of TH to AOT, a transition from catanionic vesicles to micelles was observed. The catanionic aggregates exhibited different charge properties, structures, interaction enthalpies and drug release behaviors depending on the composition. To characterize the cationic drug/anionic surfactant system, transmission electron microscopy (TEM), dynamic light scattering (DLS), isothermal titration calorimetry (ITC), conductivity, turbidity and zeta potential (ζ) measurements were performed. The drug release results indicate that the present drug-containing catanionic vesicles have promising applications in drug delivery systems. Furthermore, the percentage of drug distributed in the catanionic vesicles or micelles can be obtained by comparing the cumulative release of the corresponding aggregates with the pure drug solution.

MATERIALS
Product Number
Brand
Product Description

Tetracaine hydrochloride, European Pharmacopoeia (EP) Reference Standard
Tetracaine for system suitability, European Pharmacopoeia (EP) Reference Standard
Sigma-Aldrich
Tetracaine hydrochloride, ≥99%
Sigma-Aldrich
Tetracaine, meets USP testing specifications
Sigma-Aldrich
Tetracaine, ≥98% (TLC)
Supelco
Tetracaine hydrochloride, Pharmaceutical Secondary Standard; Certified Reference Material